GlobalData’s new report, "Canada Biopsy Procedures Outlook to 2023", provides key procedures data on the Canada Biopsy Procedures. The report provides procedure volumes within market segments - Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.
- Canada Biopsy Procedures volumes by segments - Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures. - Projections for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
Reasons to buy
- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future. - Develop market-entry and market expansion strategies.
Our reports have been used by over 10K customers, including:
2021-2025 North America Endocrine Function Testing Market-Supplier Shares, Forecasts for 20 Tests, Opportunities in the US, Canada, Mexico--Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline This new report provides analysis of the endocrine function diagnostics...
2021 North America Endocrine Function Testing Market Perspective--US, Canada, Mexico--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 20 Tests, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new report provides analysis of the endocrine...
626 pages •
By Global Industry Analysts
• May 2021
Global Medical Thermometers Market to Reach $3.2 Billion by 2027
Amid the COVID-19 crisis, the global market for Medical Thermometers estimated at US$1.9 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 8.2% over the analysis...
The North America irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 1,529.08 million by 2028 from US$ 950.83 million in 2020; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. The growth of the market is determined due to some of the key driving factors, such as increasing prevalence of irritable bowel syndrome...
2021-2025 Canada Endocrine Function Testing Market-Supplier Shares, Forecasts for 20 Tests, Opportunities--Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline This new report provides analysis of the endocrine function diagnostics market, including emerging tests,...
Summary BioMark Diagnostics Inc (BioMark Diagnostics) is an oncology-focused medical equipment company that owns and develops multiple intellectual properties in detection and quantitation of metabolites.The company’s advanced near-to- market diagnostic technologies designed to improve patient outcomes. Its products...
275 pages •
By Global Industry Analysts
• Apr 2021
- Global Hepatitis Test Solution/Diagnosis Market to Reach $3.9 Billion by 2027
- Amid the COVID-19 crisis, the global market for Hepatitis Test Solution/Diagnosis estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$3.9 Billion by 2027, growing at a CAGR of 4.7% over...
Summary Epinex Diagnostics Inc (Epinex Diagnostics) is a developer of rapid diagnostic test solutions. Its product portfolio includes over-the-counter test device, Epinex G1A Test system, Epinex ACR Test system, Epinex SimplySure PT-INR Test system and point-of-care test device.Its Epinex G1A system is rapid diabetes...
Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that provides in vitro diagnostic and pharmaceutical research products.It provides products such as sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs.SQI Diagnostic’s sqidlite is a practical benchtop system. It provides...
Medical Devices Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.